Clinical significance of glycated hemoglobin in the acute phase of ST elevation myocardial infarction

doi:10.4330/wjc.v6.i4.140

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 4

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5739)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-1) series.

Item

Count

PDF

380

WORD

269

HTML

2983

Figures (1-1)

145

Tables (1-1)

158

Sum=3935

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

917

Download

887

Sum=1804

Apr 26, 2014 (publication date) through May 9, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Cardiol. Apr 26, 2014; 6(4): 140-147
Published online Apr 26, 2014. doi: 10.4330/wjc.v6.i4.140

Full Size Figure Download Figure

Figure 1 A screening algorithm for glucose intolerance based on glycated hemoglobin. STEMI: ST-elevation myocardial infarction; HbA1c: Glycated hemoglobin A1c.

Citation: Lazzeri C, Valente S, Chiostri M, D’Alfonso MG, Gensini GF. Clinical significance of glycated hemoglobin in the acute phase of ST elevation myocardial infarction. World J Cardiol 2014; 6(4): 140-147
URL: https://www.wjgnet.com/1949-8462/full/v6/i4/140.htm
DOI: https://dx.doi.org/10.4330/wjc.v6.i4.140